These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 1296488)

  • 1. [Balanced facial hydrophilicity of ioversol: a qualitative approach of hydrophilicity].
    Meyer D; Bonnemain B; Dugast-Zrihen M; Le Greneur S
    Ann Radiol (Paris); 1992; 35(4 Pt 2):263-6. PubMed ID: 1296488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of iopamidol and ioversol in vitro and in animal studies.
    Krause W; Miyazawa T; Uchimoto R; Murayama C; Fritz-Zieroth B; Press WR; Frenzel T
    Arzneimittelforschung; 1995 Feb; 45(2):200-4. PubMed ID: 7710450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of the hydrophilic sphere of iobitridol, a new nonionic iodinated contrast agent.
    Meyer D; Petta M; Fouchet MH; Vadel M; Schaefer M; Dugast-Zrihen M; Guillemot M
    Acta Radiol Suppl; 1996; 400():8-16. PubMed ID: 8619359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of the hydrophilic sphere of non-ionic monomers: are all protected in a similar way?
    Violon D
    Br J Radiol; 2001 Dec; 74(888):1097-102. PubMed ID: 11777766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New iodinated, low-osmolar contrast media. A revised concept of hydrophilicity.
    Bonnemain B; Meyer D; Schaefer M; Dugast-Zrihen M; Legreneur S; Doucet D
    Invest Radiol; 1990 Sep; 25 Suppl 1():S104-6. PubMed ID: 2283218
    [No Abstract]   [Full Text] [Related]  

  • 6. Stereoisomerism in contrast media. Ioversol.
    Dunn J; Lin Y; Miller D; Rogic M; Neumann W; Woulfe S; White D
    Invest Radiol; 1990 Sep; 25 Suppl 1():S102-3. PubMed ID: 2283217
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo interference of Ioversol in serum and urine capillary electrophoresis: an optimized protocol for sample collection.
    Quirós C; Cillero AI; Bretaña L; García M; Prieto B; Álvarez FV
    Clin Chem Lab Med; 2018 Jan; 56(2):e53-e55. PubMed ID: 28771431
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ioversol 350: clinical experience in skull x-ray computed tomography].
    Théron J; Paugam JP; Courthéoux P
    Ann Radiol (Paris); 1991; 34(6-7):413-7. PubMed ID: 1822666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacotoxicological profile of a non-ionic LOCM at high hydrophilicity: ioversol].
    Doucet D; Idée JM
    Ann Radiol (Paris); 1992; 35(4 Pt 2):267-72. PubMed ID: 1296489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of some geometric parameters derived from molecular models of monomer nonionic contrast medium molecules with their octanol/water partition coefficient.
    Violon D
    Invest Radiol; 1996 Sep; 31(9):569-76. PubMed ID: 8877494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New x-ray contrast agents. The chemical, biological, and physical properties of 5-heterocycle substituted 2,4,6-triiodo-1,3-benzenedicarboxamide derivatives.
    Ranganathan RS; Arunachalam T; Diamantidis G; Duncan L; Emswiler J; Marinelli E; Neubeck R; Pillai R; Wedeking P; Tweedle MF
    Invest Radiol; 1991 Nov; 26 Suppl 1():S156-8; discussion S165-6. PubMed ID: 1808114
    [No Abstract]   [Full Text] [Related]  

  • 12. Physicochemical properties and degree of protein binding of iopentol.
    Skinnemoen K
    Acta Radiol Suppl; 1987; 370():33-6. PubMed ID: 2980308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clotting issue: etiologic factors in thromboembolism. I. Chemistry, pharmacology, and toxicity of angiographic contrast agents.
    Dawson P
    Invest Radiol; 1993 Nov; 28 Suppl 5():S25-30. PubMed ID: 8282499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia?
    Nyman U; Elmståhl B; Leander P; Nilsson M; Golman K; Almén T
    Radiology; 2002 May; 223(2):311-8; discussion 328-9. PubMed ID: 11997530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iodinated α-tocopherol nano-emulsions as non-toxic contrast agents for preclinical X-ray imaging.
    Li X; Anton N; Zuber G; Zhao M; Messaddeq N; Hallouard F; Fessi H; Vandamme TF
    Biomaterials; 2013 Jan; 34(2):481-91. PubMed ID: 23083930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the adverse effects of various radiographic contrast media, including ioversol, a new low-osmolarity medium. I. Histamine release.
    Akagi M; Tasaka K
    Methods Find Exp Clin Pharmacol; 1991; 13(6):377-84. PubMed ID: 1715500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The new nonionic contrast preparation for myelography iotrolan].
    Sviridov NK
    Zh Vopr Neirokhir Im N N Burdenko; 1994; (2):35-6. PubMed ID: 8209595
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preliminary study and clinical evaluation method of ioversol in angiocardiography--establishment of safety evaluation parameters and reliability of radiographic quality evaluation].
    Matsuyama S; Kuribayashi S; Ide M; Shigeta A; Umemura J; Harada J; Yamada T; Himi K; Takemoto A; Morimoto S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jun; 50(6):620-36. PubMed ID: 2235313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and stability of iopentol.
    Skinnemoen K; Fagervoll R; Aanstad L; Jacobsen T
    Acta Radiol Suppl; 1987; 370():37-40. PubMed ID: 2980309
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.